Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Lantheus Stock Is Soaring Today

TheMotleyFool

0 0

Why Lantheus Stock Is Soaring TodayPhoto, wide shot, wide-angle lens, Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png

Shares of Lantheus Holdings (NASDAQ: LNTH) were soaring 17.1% as of 11:01 a.m. EDT on Thursday. The big jump came after the company announced that the Food and Drug Administration had approved Pylarify, an imaging agent used to identify prostate cancer.

Today's significant gain for the life sciences stock underscores how optimistic investors are about the market potential for Pylarify. It's the first imaging agent to win FDA approval that's targeted to the prostate-specific membrane antigen (PSMA) for use in positron emission tomography.

Image source: Getty Images.

Source Fool.com

Like: 0

LNTH

Share